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Background: Reactive oxygen species (ROS) is one of the pathogenic factors responsible for intestinal injury in
Ulcerative colitis (UC). Nuclear factor erythroid-2 related factor 2 (Nrf2) plays a critical role against ROS factors
to conserve epithelial integrity. This study aimed to localize Nrf2 and IL-17A protein in the inﬂamed mucosa of
patients with ulcerative colitis. The gene expression of Nrf2 was also correlated with GST-A4 and PRDX1.
Materials and methods: A total of 20 patients and 20 healthy controls with deﬁnite UC based on the clinical
criteria were enrolled for this study. The expression pattern of Nrf2 and IL-17A protein was compared in in-
ﬂamed and non-inﬂamed colonic biopsies by immunohistochemical staining. Nrf2, GST-A4 and PRDX1 gene
expression were determined by real-time polymerase chain reaction (RT-PCR).
Results: In inﬂamed colonic biopsies, an increased level of Nrf2 protein factor was detected in epithelial cells.
Conversely, IL-17A protein was presented more in mononuclear cells in mucosa and lamina propria regions. A
signiﬁcant increase of Nrf2, GST-A4 gene expression was observed in both mild and severe patients with ul-
cerative colitis. GST-A4 gene expression indicated a high exponential rate in logistic regression.
Conclusion: Oxidative stress in inﬂamed colonic tissue can induce Nrf2 gene expression. The performance of Nrf2
transcription factor may lead to the induction of GST-A4 and PRDX1. IL-17A is less detected in intestinal inﬂ-
ammation, presenting Nrf2 factor. The present ﬁndings suggest that Nrf2 function in the gut plays a role in
arresting both inﬂammatory response and oxidative damages of UC.
1. Introduction
The inﬂammatory bowel diseases (IBDs) has a wide range of asso-
ciated disorders like ulcerative colitis (UC), characterised by recurrent
chronic and incurable inﬂammatory conditions in the colon and rectum
[1,2]. The interaction between genetic, nutritional and environmental
agents initially presents more of the inﬂammatory conditions in UC [3].
Potentially, Inﬂammation damages the mucosal barrier function and
amplify inﬂammatory response in the gastrointestinal tract [4]. Recent
investigations have also indicated an association to exist between the
degree of inﬂammation and the enhanced production of reactive
oxygen species (ROS) such as nitric oxide and superoxide [5]. Under
oxidative stress, nuclear factor erythroid 2 related factor 2 (Nrf2) can be
released from Keap1 and translocates into the nucleus of cells [6]. The
Nrf2 is mainly expressed in the nucleus of epithelial cells to conserve
the intestinal integrity. The protective eﬀects of Nrf2 in a chronic colitis
mice caused lower expression of inﬂammatory cytokines [7]. Activated
Nrf2 has the potential to suppress interleukin (IL)-17 expression in
autoimmune disease [8]. In murine dextran sodium sulfate (DSS)-in-
duced colitis, IL-17 augments inﬂamed intestinal by pro-inﬂammatory
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eﬀects on epithelium [9]. In addition to high level of IL-17 in serum and
tissue, the existence of T helper-17 illustrates the pathogenesis role of
this cytokine in the UC patients (Graphical abstract) [10,11].
The Nrf2 factor controls the expression of phase2 antioxidant en-
zymes by binding to the Antioxidant Response Element (ARE) region
[12]. Peroxiredoxin-1 (PRDX1), a cytoprotective gene, is induced by
Nrf2 activation under oxidative stress condition to protect the cell
particularly against superoxide. PRDX1 can act as chaperone, pro-
tecting protein factors through thiol-speciﬁc groups in the cytoplasm
[13]. PRDX1 enzyme engages in several redox factors like apurinic/
apyrimidinic endonuclease1 (APE1), consequently causing a reduction
in inﬂammatory cytokines [14]. Nrf2 can also target ARE region to
induce Glutathione S-transferase alpha 4 (GST-A4) against oxidative
damage. In response to accumulation of lipid peroxidation, GST-A4
attenuates toxic lipid aldehydes by conjugating to glutathione [15].
GST-A4 is dominantly capable of detoxifying trans-4-hydroxy-2-
nonenal (4-HNE) which is considered as an endogenous mutagen in
inﬂammation-associated colorectal cancer [16].
In this study, the Nrf2 gene expression and its relation with mRNA
level of PRDX1 and GST-A4 in control colonic biopsy compared to UC
patient, will be examined. The expression pattern of the Nrf2 and IL-
17A protein in histological tissues will be assessed. A negative protein
expression between Nrf2 and IL-17A will be identiﬁed. Moreover, Nrf2
factor is more presented in mucosa layer of biopsies. These data suggest
that GST-A4 gene expression appears to be dependent on Nrf2 tran-
scription factors.
2. Materials and methods
2.1. Sample collection and preparation
The study group comprised of 20 patients with UC and 21 healthy
individuals as control (Table 1). Over the period of 6 months in 2017,
all cases were attended in Gastroenterology Unit of Hajar hospital,
Shahrekord, Iran, from January to May 2017. Prior to the colonoscopy
procedure, clinical information of UC patients such as age, gender, food
habits, stress, medicine consumption and history of abdominal surgery
were collected by opt query and medical ﬁles. The disease activity
index (DAI) of ulcerative colitis was marked in regard to the weight
loss, blood in the stool and stool consistency [17]. In addition to the
clinical criteria, inﬂammation extension in colonoscopy and histolo-
gical manifests were analyzed based on the Montreal Classiﬁcation for
the conﬁrmation of UC [18]. 14 active UC patients had a mild proc-
tosigmoiditis (inﬂammation was limited from the colorectum distal to
the splenic ﬂexure/erythema is detected in rectum and sigmoid, de-
creased friability and vascular pattern/Montreal class: E2). Six severe
patients had consumed corticosteroid six months before sampling date
(Involvement extends proximal to the splenic ﬂexure/Montreal class:
E3). The Control group was selected among healthy individuals without
immune-mediated diseases. These subjects were undergone colono-
scopy due to screening for colorectal cancer or polyp surveillance
without inﬂammatory disease or any medication. This project was
approved by Shahrekord University of Medical Sciences Ethics Com-
mittee, and all informed participants complemented a written consent.
2.2. RNA isolation and quantitative RT-PCR
The total RNA was extracted from nitrogen frozen colon biopsies
with TRIzol® reagent (Invitrogen/Thermo Fisher Scientiﬁc, Inc, catalog
number. 15596026). The concentration of each RNA samples was de-
termined by Thermo Scientiﬁc™ NanoDrop 2000. The 260/280 - 260/
230 ratios for samples were measured, and cDNAs were synthesized
using the Revert Aid ﬁrst-strand cDNA synthesis kit (Thermo Scientiﬁc,
K1622) with 1.5 μg of RNA in a reaction volume of 20 μL. To eliminate
possible DNA contamination, DNaseI (Fermentas EN0521) enzyme was
used. The real-time RT-PCR to indicate the quantiﬁcation of mRNA was
performed on a Rotor-Gene RG-300 (Corbett Research, Sydney, AU)
and SYBR Green Real-time PCR Master Mix Kit (TAKARA, Japan, cat-
alog number. RR820Q) according to the protocol provided by the
manufacturer. Then, three pairs primers were exploited for the speciﬁc
ampliﬁcation of Nrf2, PRDX1 and GST-A4 (Supplement File 1). The
primers were designed by Primer3.0 (http://bioinfo.ut.ee/primer3-0.4.
0) web-based server. We checked out the lack of SNPs in the genomic
region corresponding to the 3′ ends of primers by looking through the
dbSNP database. The primers speciﬁcity was checked by the in-silico-
PCR tool in UCSC genome browser and Primer blast of NCBI genome
browser. Thermal cycling for running a process started the denaturation
step at 95 °C for 5min ﬁrst denaturation step at 95 C for 5min and
followed by 38 cycles of 95 °C for 15 s, 61 °C for 20 and 72 for 25 s.
Melting curve conﬁrmed the ampliﬁcation speciﬁcity of three gene
expression of Nrf2, PRDX1 and GST-A4 were normalised versus GAPDH
as an internal control and relative quantiﬁcation (2−ΔΔCq) showed the
fold changes of each mRNA.
2.3. Immunohistochemistry
Immunohistochemical staining was implemented with the strepta-
vidin biotin peroxidase-complex method according to the Abcam pro-
tocol [[19]]. Brieﬂy, sections of biopsy specimens were cut into 4-μm-
thick sections and stuck on poly-L-lysine slides. The sections were de-
paraﬃnized and rehydrated after placed in xylene and a series of al-
cohols (100%, 100%, 80% and 70%). In antigen retrieving stage, sec-
tions immersed in citrate buﬀer (10mM Sodium Citrate, 0.05% Tween
20, pH 6.0) were exposed to pressure for 20min. Sections were then
incubated with protein block (Abcam, England) containing albumin for
120min to prevent nonspeciﬁc background staining. Rabbit anti-
human Nrf2 antibody (ab31163, Abcam, UK) at a 1:700 dilution and
anti-IL17A antibody (ab79056) were incubated overnight 4 C. It is
followed by adding 0.3% H O2 2 solved in TBS to inhibit endogenous
peroxidase activity. After incubating biotinylated IgG antibody
(ab93697, Abcam, UK) and Streptavidin-Peroxidase Plus at room tem-
perature, 3-diaminobenzidine tetrahydrochloride DAB (ab94665,
Abcam, UK) was used to visualise speciﬁc antigen. Sections were
counterstained with hematoxylin and washed with cool water. The
number of nuclei with positive reactivity for Nrf2 and IL-17A were
counted in the 3 areas of mucosal epithelium and lamina propria. The
expression level of Nrf2 and IL-17A were assessed using a 6-score
system (0 = negative, 0.5= 0–5% positive, 1= 5–15% positive,
2= 16%–40% positive, 3= 41%–90% positive, and 5 more than 90%
positive).
2.4. Statistical analysis
All data were presented as mean ± SD and were evaluated by
SPSS19.0 (SPSS Inc, Chicago, IL, USA) and GraphPad Prism software
version 5.0 (GraphPad Software, La Jolla, CA, USA). The distribution of
data was normal and the relationship between age of subjects and
groups was addressed with the Fischer exact test. Unpaired t-test was
Table 1
demographic information of the patients.
Control Mild colitis Severe colitis P value
Age 33.81 ± 8.85 35.43 ± 9.55 32.00 ± 9.06 0.729
Gender
(male/female)
12/9 7/7 3/3 0.913
Smoking 9.5% 21.4% 46.7% 0.019a
Habitat
(rural/urban)
2/19 4/10 3/3 0.078
History of abdominal
surgery
19% 64.3% 50% 0.295
a Number of smoking people were statistically signiﬁcance.
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used to compare the 2 groups and multiple comparisons were done by
Tukey post hoc. Pearson's correlation analysis was used to estimate the
correlations between Nrf2 gene expression and GST-A4 and PRDX1
gene expression. Diﬀerences calculating in P-values< 0.05 were con-
sidered to be statistically signiﬁcant. A multivariate logistic regression
model was used to assess correlation between gene expression levels
and existence of ulcerative colitis.
3. Results
3.1. Increased expression of Nrf2 at inﬂammatory locations of IBD tissues
We ﬁrstly evaluated the gene expression of the Nrf2 in the colonic
tissue of subjects with UC compared to control samples. As it was re-
ported previously, Nrf2-P was increased in the colonic epithelium of UC
[20]. Accordingly, we found a remarkable increase of Nrf2 gene ex-
pression by real-time PCR in inﬂamed colonic tissues compared to
control samples (P=0.002, Fig. 1A). Moreover, mRNA level of Nrf2 in
both mild and severe patients enhanced considerably; however, the
comparison of Nrf2 gene expression between severe and mild patients
did not show any statistical signiﬁcation (P>0.05, Fig. 1B). The
samples were immunostained with anti-Nrf2 antibody in order to
characterise the locations of Nrf2 protein factor in the inﬂamed mucosa.
Immunohistochemistry analysis indicated that intestinal epithelial cells
(IEC) were a major source of Nrf2 in tissues, while lamina propria
mononuclear cells appeared fewer Nrf2 staining. Interestingly, strong
cytoplasmic staining of Nrf2 factor was detected among IECs in UC
samples (3 < score< 5) compared with control samples
(2 < score< 3) (Fig. 2A, C).
3.2. The diﬀerent pattern of IL-17A and Nrf2 protein expression in
inﬂammatory biopsies
As previous investigations showed that IL-17A was mostly expressed
in the inﬂamed colonic tissue of UC patients. In contrast to the re-
petitive stain of Nrf2 in IECs, IL-17A was dominantly observed among
immune cells (3 < score< 5) at mucosa layer (Fig. 2B). On the other
hand, we found more labelling of IL-17A rather than Nrf2 staining at
lamina propria regions (Fig. 2B). It means that, Nrf2 negatively corre-
lated with IL-17A staining (P=0.004, Fig. 3). In the normal mucosa,
IL-17A was speciﬁc for mocusa regions, but it was not detected in la-
mina propria (Fig. 2D). IL-17A is less detected in intestinal inﬂamma-
tion presenting Nrf2 factor. Apparently, IL-17A staining was declined in
the control samples rather than inﬂamed colonic tissue.
3.3. The mRNA expressions of GST-A4 and PRDX1 in ulcerative colitis
Real-time PCR was used to evaluate the mRNA expressions of GST-
A4 and PRDX1 in the colonic samples of the control group and UC
patients. The expression of GST-A4 mRNA in patients was two times
higher than controls (P < 0.001); however, the comparison of GST-A4
gene expression between severe and mild samples did not show any
statistical signiﬁcation (Fig. 4A and B). In addition, there was no sig-
niﬁcant diﬀerence in mRNA level of PRDX1 (Fig. 4C and D). As can be
observed in the Table 2, the mRNA levels of GST-A4 and PRDX1 con-
siderably correlated with that of in Nrf2. In multivariable logistic re-
gression analysis, the existence of ulcerative colitis was signiﬁcantly
associated with high level of GST-A4 gene expression (95% CI,
3.602–4457.1, P=0.008) (Table 3).
4. Discussion
The acquisition of inﬂammatory phenotypes in UC correlates with
conserving signals derived from NRF2. Epithelial Nrf2 activation en-
hances intestinal wound healing and protects from apoptosis during
oxidative injury [20,21]. The objective of this study was to recognize
whether Nrf2 can be an eﬃcient factor to arrest il-17 and promote GST-
A4 and PRDX1 enzymes in UC patients. In addressing this question, the
up-regulation of Nrf2 gene expression was observed in our study, sug-
gesting a possible preservation role for Nrf2 factor in the colonic tissue
of UC patient. With regards to histological analysis, dominant presence
of the Nrf2 factor in epithelial cells is likely to be an alternative in
response to chronic inﬂammation. In a similar study, phosphorylated
form of Nrf2, which is a nuclear type of this factor, was reported in IECs
patients suﬀering from UC. However, elevated Nrf2 activity may give
rise to the expression of proteasomal proteins resulting in colitis asso-
ciated cancer process [20]. The active forms of Nrf2 factor con-
stitutively protect epithelium integrity against eﬀect of inﬂammatory
cytokines in chronic mice colitis [5,7]. DSS-treated Nrf2-deﬁcient mice
exhibited colitis symptoms much earlier than WT mice [22]. Never-
theless, unstable Nrf2 proteins are not able to implement antioxidant
defenses in chronic obstructive pulmonary disease (COPD) despite the
high amount of this factor in bronchial cells [23]. Unstable Nrf2 factor
in cytosol is usually tagged by the ubiquitin ligase adapter for protea-
some degradation [24].
Cellular stress has been shown to induce inﬂammatory mediators in
various cell systems in IBD [25]. Animal models indicated that oxida-
tive stress is sufﬁcient for the initiation of intestinal inﬂammation and
extension to other organs [26]. Macrophage Nrf2 activation suppresses
inﬂammatory cytokine by binding to the upstream region of M1-in-
duced genes [27]. To investigate the interaction expression between IL-
17A and Nrf2 involved in IBD mucosa, immunohistochemical stain of
IL-17A and Nrf2 antibodies was used in colonic tissues. It seemed that
mononuclear cells were more potent in inducing IL-17A in mucosa layer
and lamina propria in comparison with the Nrf2 factor. It is speculated
that production of IL-17A was irreversibly regulated by Nrf2, especially
Fig. 1. A) Nrf2 mRNA level was evaluated in
20 UC and 21 control colonic tissues. Nrf2 gene
expression in UC and control mucosa was
shown. The data from the real-time PCR for
human Nrf2 were normalized versus GAPDH.
B) Nrf2 gene was signiﬁcantly overexpressed in
endoscopic specimens in mild and severe pa-
tients rather than control. UC: ulcerative co-
litis; F.C: fold change.
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among epithelial and immune cells (Fig. 3). Activated Nrf2 is capable of
inducing heme oxygenase-1 (Hmox-1) by which the IL-17 protein ex-
pression is reduced in mice with encephalomyelitis [8]. Likewise,
Hmox-1 modulates IL-17 produced by T helper-17 in a mouse model of
colitis [28]. In fact, IL-17 commonly has an inﬂammatory mediator that
is activated by multitude cytokines of tissue-damaging in IBD. The in-
duction of IL-17 is mediated by TNF-a, IL-1b, IL-6, GM-CSF, G-CSF. IL-
17 is considered as a recruitment activation and migration for neu-
trophils. The retinoic orphan receptor gamma(t) (RORct) factor, a
transcription factor of Th17 cell diﬀerentiation, is found to be expressed
Fig. 2. Immunohistochemistry analysis of UC and normal colonic tissues for Nrf2 and IL-17A. Formalin-ﬁxed and parafﬁn-embedded were stained with Nrf2 and IL-
17A antibodies. A) IECs were a major source of Nrf2 in colonic UC biopsies compared to mononuclear cells. B) IL-17A has been stained in mononuclear cells in both
mucosa and lamina propria regions of UC biopsies. C) Nrf2 in control biopsies dominantly appeared in IECs. D) On the contrary, IL-17A presented into mononuclear
cells in control biopsies.
Fig. 3. The Immunohistochemistry data are
presented for all patients diagnosed as the UC
patients compared with control subjects.
Staining scores from UC were correlated be-
tween IL-17A and Nrf2. The A) mucosa layer
and B) lamina propria were analyzed based on
a 6-score system (0 = negative, 0.5 < 5%
positive, 1 < 15% positive, 2 < 16%–40%
positive, 3 < 41%–90% positive, and 5 more
than 90% positive).
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particularly in lamina propria T cells of patients with Crohn's disease.
IL-17A was also increased at inﬂamed mucosa tissues in addition to
mononuclear cells in lamina propria regions of patients suﬀering from
UC [10,29].
Oxidative stress has been implicated in the destruction of the co-
lonic epithelium, and may cause damage to the DNA. Numerous in-
vestigations conﬁrmed that mucosal damages are sufﬁcient for the in-
cidence of neoplasias [30,31]. To protect cell structure, antioxidant
enzymes can be expressed when the Nrf2 transcription factor binds to
the ARE sequence [12]. In this study, attempt was made to determine
the relevant transcriptional processes of PRDX1 and GST-A4 induced by
the Nrf2 transcription factor. The PRDX1 function with active-site cy-
steine suggests a speciﬁc chaperones role in the oxidative condition
[32]. PRDX1 is clearly reduced upon loss of Nrf2 in human lung cancer
[33]. Although PRDX1 gene expression in our analysis had a positive
correlation with that of Nrf2, the increase in the level of PRDX1 mRNA
was not the same as Nrf2 mRNA in the patient group. On the other
hand, PRDX1 did not seem to be eﬃcient in protection from UC disease
according to the outcomes of logistic regression. The PRDX1 enzyme
was evident in the mitochondrial and cytoplasmic parts of intestinal
epithelial cells in patients with UC. Therefore, the accumulation of
PRDX1 enzymes in speciﬁc locations probably is a response to mucosal
injury instead of elevating gene expression [34]. To the best of our
knowledge, GST-A4 mRNA level was increased in both mild and severe
state of the patient group. Besides the signiﬁcant correlation between
Fig. 4. The gene expressions of GSTA4 and PRDX1 were compared between control and patient group. The real-time PCR data were normalised versus GAPDH as the
housekeeping gene. A considerable increase was observed in gene expression of GSTA4 in UC patients (both mild and severe state) compared to control group (A) and
(B). We did not detect any signiﬁcant diﬀerence in mRNA level of PRDX1 (C) and (D). P-values less than 0.05 is statistically signiﬁcant.
Table 2
Pearson correlations for GSTA4 and PRDX1 with Nrf2.
Group
Gene Control
r (P - value)
Patient
r (P - value)
Mild
r (P - value)
Severe
r (P - value)
GSTA4 0.624 (0.003) 0.763 (0.001) 0.809 (0.001) 0.637 (0.174)
PRDX1 0.596 (0.004) 0.564 (0.010) 0.642 (0.013) 0.397 (0.436)
Table 3
Coeﬃcients of the logistic regression analysis for the existence of ulcerative
colitis.
Gene Regression
coeﬃcient
(β)
Exp (β) Standard
error
signiﬁcance 95% C.I for Eep (B)
Lower Upper
Nrf2 −0.293 0.746 0.833 0.725 0.146 3.822
GSTA4 4.842 126.708 1.817 0.008a 3.602 4457.1
PRDX1 1.053 2.865 1.809 0.561 0.083 99.286
a The existence of ulcerative colitis was signiﬁcantly associated with high
level of GST-A4 gene expression.
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GST-A4 and Nrf2 gene expression, the exponential rate of logistic re-
gression illustrated that GST-A4 may play a preservation role in in-
ﬂamed colonic tissues (Table 3). Previous ﬁndings indicated that Nrf2 is
accompanied with mitogen-activated protein kinase (MAPK) pathway
resulting in up-regulation of GST-A4 gene expression. Indeed, the c-Jun
factor can induce GST-A4 after epithelial cells are exposed to ROS
factors [16,35]. It is more likely that the activation of MAPK pathway
collaborates to increase GST-A4 gene expression in the patient group.
Although these detoxiﬁcation enzymes promote antitumor potent in UC
disease, Nrf2 is identiﬁed as the master key regulator of actual carci-
nogenesis in inﬂammation-associated colorectal cancer [16,36].
In summary, we demonstrated that Nrf2 transcription factor was
highly located in the epithelial cells of UC patients but IL-17A was
identiﬁed more in immune cells rather than epithelial cells. One lim-
itation of our analysis was that molecular interplay between the Nrf2
factor and IL-17A was not particularly applied in the ex-vivo study. Our
data suggest that inﬂamed colonic cells under oxidative stress provoke
Nrf2 transcription by which gene expression of GST-A4 and PRDX1
were elevated; however, PRDX1 gene expression is rather independent
of Nrf2.
5. Conclusion
This study conﬁrms an irreversible associations between the Nrf2
factor and IL-17A protein expression. Future investigations should focus
on the molecular interaction between them, ideally using isolated IECs
of UC patients or colonic cell line cultured in the inﬂammatory en-
vironment. There were no diﬀerences detected in gene expression of
PRDX1. Future studies should also provide the opportunity to ﬁnd the
anti-oxidative stress performance in inﬂamed intestine, which would
lead to a better understanding of this inﬂammatory disease.
Ethics approval and consent to participate
The study protocol was approved by the local medical ethics com-
mittee of Shahrekord University of Medical Sciences Ethics Committee
with a number: IR.SKUMS.REC.1395.313.
Consent for publication
Not applicable.
Availability of data and materials
The datasets generated and/or analysed during the current study are
not publicly available due the principle of conﬁdentiality of funding but
are available from the corresponding author on reasonable request.
Competing interests
The authors declare that they have no competing interests.
Disclosure statements
This study was ﬁnancially supported by research deputy of
Shahrekord University of Medical Sciences with research number:
1395-01-74-3214 and with grant-funded number 2337.
Authors’ contributions
Conceived and designed the experiments: MSG. Conducted the ex-
periments: HS, MG. Analysed the data: FD. Contributed reagents/ma-
terials/analysis tools: MS, GR, AS. Wrote the paper: MSG, HS, MG. All
authors read and approved the ﬁnal manuscript.
Acknowledgments
The authors are grateful to the staﬀs of Students Research
Committee, Shahrekord University of Medical Sciences, Shahrekord,
Iran. The authors are also grateful to the staﬀs of Cellular & Molecular
Research Center, Shahrekord University of Medical Sciences and the
authorities of the endoscopy unit of Shahrekord Hajar Hospital for their
helpful cooperation.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in the
online version, at https://doi.org/10.1016/j.prp.2018.06.001.
References
[1] A.N. Ananthakrishnan, C.N. Bernstein, D. Iliopoulos, A. Macpherson, M.F. Neurath,
R.A.R. Ali, S.R. Vavricka, C. Fiocchi, Environmental triggers in IBD: a review of
progress and evidence, Nat. Rev. Gastroenterol. Hepatol. 15 (2017) 39.
[2] M.F. Neurath, Cytokines in inﬂammatory bowel disease, Nat. Rev. Immunol. 14
(2014) 329–343.
[3] P. Hindryckx, V. Jairath, G. D’Haens, Acute severe ulcerative colitis: from patho-
physiology to clinical management, Nat. Rev. Gastroenterol. Hepatol. 13 (2016)
654–664.
[4] J.R. Turner, Molecular basis of epithelial barrier regulation: from basic mechanisms
to clinical application, Am. J. Pathol. 169 (2006) 1901–1909, http://dx.doi.org/10.
2353/AJPATH.2006.060681.
[5] G. Jena, P.P. Trivedi, B. Sandala, Oxidative stress in ulcerative colitis: an old con-
cept but a new concern, Free Radic. Res. 46 (2012) 1339–1345, http://dx.doi.org/
10.3109/10715762.2012.717692.
[6] A. Matsuura, T. Ishima, Y. Fujita, Y. Iwayama, S. Hasegawa, R. Kawahara-Miki,
M. Maekawa, M. Toyoshima, Y. Ushida, H. Suganuma, S. Kida, T. Yoshikawa,
M. Iyo, K. Hashimoto, Dietary glucoraphanin prevents the onset of psychosis in the
adult oﬀspring after maternal immune activation, Sci. Rep. 8 (2018) 2158, http://
dx.doi.org/10.1038/s41598-018-20538-3.
[7] A. Gerstgrasser, H. Melhem, I. Leonardi, K. Atrott, M. Schäfer, S. Werner, G. Rogler,
I. Frey-Wagner, Cell-speciﬁc activation of the Nrf2 antioxidant pathway increases
mucosal inﬂammation in acute but not in chronic colitis, J. Crohns Colitis 11 (2016)
jjw172, http://dx.doi.org/10.1093/ecco-jcc/jjw172.
[8] T.K. Pareek, A. Belkadi, S. Kesavapany, A. Zaremba, S.L. Loh, L. Bai, M.L. Cohen,
C. Meyer, K.T. Liby, R.H. Miller, M.B. Sporn, J.J. Letterio, Triterpenoid modulation
of IL-17 and Nrf-2 expression ameliorates neuroinﬂammation and promotes re-
myelination in autoimmune encephalomyelitis, Sci. Rep. 1 (2011) 201, http://dx.
doi.org/10.1038/srep00201.
[9] Z. Zhang, M. Zheng, J. Bindas, P. Schwarzenberger, J.K. Kolls, Critical role of IL-17
receptor signaling in acute TNBS-induced colitis, Inﬂamm. Bowel Dis. 12 (2006)
382–388, http://dx.doi.org/10.1097/01.MIB.0000218764.06959.91.
[10] G. Hundorfean, M.F. Neurath, J. Mudter, Functional relevance of T helper 17
(Th17) cells and the IL-17 cytokine family in inﬂammatory bowel disease, Inﬂamm.
Bowel Dis. 18 (2012) 180–186, http://dx.doi.org/10.1002/ibd.21677.
[11] M. Leppkes, C. Becker, I.I. Ivanov, S. Hirth, S. Wirtz, C. Neufert, S. Pouly,
A.J. Murphy, D.M. Valenzuela, G.D. Yancopoulos, B. Becher, D.R. Littman,
M.F. Neurath, RORγ-expressing Th17 cells induce murine chronic intestinal in-
ﬂammation via redundant eﬀects of IL-17A and IL-17F, Gastroenterology 136
(2009) 257–267, http://dx.doi.org/10.1053/j.gastro.2008.10.018.
[12] M.-C. Lu, J.-A. Ji, Y.-L. Jiang, Z.-Y. Chen, Z.-W. Yuan, Q.-D. You, Z.-Y. Jiang, An
inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic
cells and alleviates experimental colitis, Sci. Rep. 6 (2016) 26585, http://dx.doi.
org/10.1038/srep26585.
[13] R.A. Egler, E. Fernandes, K. Rothermund, S. Sereika, N. De Souza-Pinto, P. Jaruga,
M. Dizdaroglu, E.V. Prochownik, Regulation of reactive oxygen species, DNA da-
mage, and c-Myc function by peroxiredoxin 1, Oncogene 24 (2005) 8038–8050,
http://dx.doi.org/10.1038/sj.onc.1208821.
[14] H. Nassour, Z. Wang, A. Saad, A. Papaluca, N. Brosseau, E.B. Aﬀar, M.A. Alaoui-
Jamali, D. Ramotar, Peroxiredoxin 1 interacts with and blocks the redox factor
APE1 from activating interleukin-8 expression, Sci. Rep. 6 (2016) 29389, http://dx.
doi.org/10.1038/srep29389.
[15] Y.C. Awasthi, K.V. Ramana, P. Chaudhary, S.K. Srivastava, S. Awasthi, Regulatory
roles of glutathione-S-transferases and 4-hydroxynonenal in stress-mediated sig-
naling and toxicity, Free Radic. Biol. Med. 111 (2017) 235–243, http://dx.doi.org/
10.1016/J.FREERADBIOMED.2016.10.493.
[16] Y. Yang, M.M. Huycke, T.S. Herman, X. Wang, Glutathione S-transferase alpha 4
induction by activator protein 1 in colorectal cancer, Oncogene 35 (2016)
5795–5806, http://dx.doi.org/10.1038/onc.2016.113.
[17] K.W. Schroeder, W.J. Tremaine, D.M. Ilstrup, Coated oral 5-aminosalicylic acid
therapy for mildly to moderately active ulcerative colitis, N. Engl. J. Med. 317
(1987) 1625–1629, http://dx.doi.org/10.1056/NEJM198712243172603.
[18] J. Satsangi, M.S. Silverberg, S. Vermeire, F. Colombel, The montreal classiﬁcation of
inﬂammatory bowel disease: controversies, consensus, and implications, Gut 55
(2006) 749–753, http://dx.doi.org/10.1136/gut.2005.082909.
[19] IHC protocol for paraﬃn, frozen and free ﬂoating sections (n.d.). http://www.
M. Sabzevary-Ghahfarokhi et al. Pathology - Research and Practice 214 (2018) 1149–1155
1154
abcam.com/protocols/immunostaining-paraﬃn-frozen-free-ﬂoating-protocol
(Accessed 09 March 2018).
[20] M.-L. Kruse, M. Friedrich, A. Arlt, C. Röcken, J.-H. Egberts, S. Sebens, H. Schäfer,
Colonic lamina propria inﬂammatory cells from patients with IBD induce the nu-
clear factor-E2 related factor-2 thereby leading to Greater proteasome activity and
apoptosis protection in human colonocytes, Inﬂamm. Bowel Dis. 22 (2016)
2593–2606, http://dx.doi.org/10.1097/MIB.0000000000000925.
[21] R. Foresti, C. Bucolo, C.M.B. Platania, F. Drago, J.-L. Dubois-Randé, R. Motterlini,
Nrf2 activators modulate oxidative stress responses and bioenergetic proﬁles of
human retinal epithelial cells cultured in normal or high glucose conditions,
Pharmacol. Res. 99 (2015) 296–307, http://dx.doi.org/10.1016/J.PHRS.2015.07.
006.
[22] W.O. Osburn, B. Karim, P.M. Dolan, G. Liu, M. Yamamoto, D.L. Huso, T.W. Kensler,
Increased colonic inﬂammatory injury and formation of aberrant crypt foci in Nrf2-
deﬁcient mice upon dextran sulfate treatment, Int. J. Cancer 121 (2007)
1883–1891, http://dx.doi.org/10.1002/ijc.22943.
[23] N. Mercado, R. Thimmulappa, C.M.R. Thomas, P.S. Fenwick, K.K. Chana,
L.E. Donnelly, S. Biswal, K. Ito, P.J. Barnes, Decreased histone deacetylase 2 impairs
Nrf2 activation by oxidative stress, Biochem. Biophys. Res. Commun. 406 (2011)
292–298, http://dx.doi.org/10.1016/j.bbrc.2011.02.035.
[24] A. Cuadrado, Structural and functional characterization of Nrf2 degradation by
glycogen synthase kinase 3/β-TrCP, Free radic, Biol. Med. 88 (2015) 147–157,
http://dx.doi.org/10.1016/J.FREERADBIOMED.2015.04.029.
[25] A. Bhattacharyya, R. Chattopadhyay, S. Mitra, S.E. Crowe, Oxidative stress: an es-
sential factor in the pathogenesis of gastrointestinal mucosal diseases, Physiol. Rev.
94 (2014) 329–354, http://dx.doi.org/10.1152/physrev.00040.2012.
[26] Z. Wang, S. Li, Y. Cao, X. Tian, R. Zeng, D.-F. Liao, D. Cao, Oxidative stress and
carbonyl lesions in ulcerative colitis and associated colorectal cancer, Oxid. Med.
Cell. Longev. 2016 (2015) 9875298, http://dx.doi.org/10.1155/2016/9875298.
[27] E.H. Kobayashi, T. Suzuki, R. Funayama, T. Nagashima, M. Hayashi, H. Sekine,
N. Tanaka, T. Moriguchi, H. Motohashi, K. Nakayama, M. Yamamoto, Nrf2 sup-
presses macrophage inﬂammatory response by blocking proinﬂammatory cytokine
transcription, Nat. Commun. 7 (2016) 1–14, http://dx.doi.org/10.1038/
ncomms11624.
[28] W. Zhong, Z. Xia, D. Hinrichs, J.T. Rosenbaum, K.W. Wegmann, J. Meyrowitz,
Z. Zhang, Hemin exerts multiple protective mechanisms and attenuates dextran
sulfate sodium–induced colitis, J. Pediatr. Gastroenterol. Nutr. 50 (2010) 132–139,
http://dx.doi.org/10.1097/MPG.0b013e3181c61591.
[29] A. D’Ambrosio, A. Cossu, A. Amendola, A. Zandri, A. Butera, M. Sanchez, M. Biﬀoni,
A. Pronio, C. Montesani, A. Kohn, R. Pica, M. Boirivant, Lamina propria CD4+LAP
+ regulatory T cells are increased in active ulcerative colitis but show increased IL-
17 expression and reduced suppressor activity, J. Crohns Colitis 10 (2016) 346–353,
http://dx.doi.org/10.1093/ecco-jcc/jjv216.
[30] A. Keshavarzian, A. Banan, A. Farhadi, S. Komanduri, E. Mutlu, Y. Zhang,
J.Z. Fields, Increases in free radicals and cytoskeletal protein oxidation and nitra-
tion in the colon of patients with inﬂammatory bowel disease, Gut 52 (2003)
720–728.
[31] J. Bollrath, T.J. Phesse, V.A. von Burstin, T. Putoczki, M. Bennecke, T. Bateman,
T. Nebelsiek, T. Lundgren-May, Ö. Canli, S. Schwitalla, gp130-mediated Stat3 ac-
tivation in enterocytes regulates cell survival and cell-cycle progression during
colitis-associated tumorigenesis, Cancer Cell 15 (2009) 91–102.
[32] S.G. Rhee, H.A. Woo, Multiple functions of peroxiredoxins: peroxidases, sensors and
regulators of the intracellular messenger H2 O2, and protein chaperones, Antioxid.
Redox Signal. 15 (2011) 781–794, http://dx.doi.org/10.1089/ars.2010.3393.
[33] Y.J. Kim, J.Y. Ahn, P. Liang, C. Ip, Y. Zhang, Y.M. Park, Human prx1 gene is a target
of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor
biology, Cancer Res. 67 (2007) 546–554, http://dx.doi.org/10.1158/0008-5472.
CAN-06-2401.
[34] S.-Y. Hsieh, T.-C. Shih, C.-Y. Yeh, C.-J. Lin, Y.-Y. Chou, Y.-S. Lee, Comparative
proteomic studies on the pathogenesis of human ulcerative colitis, Proteomics 6
(2006) 5322–5331, http://dx.doi.org/10.1002/pmic.200500541.
[35] I. Moriyama, S. Ishihara, M.A.K. Rumi, M.D.M. Aziz, Y. Mishima, N. Oshima,
C. Kadota, Y. Kadowaki, Y. Amano, Y. Kinoshita, Decoy oligodeoxynucleotide tar-
geting activator protein-1 (AP-1) attenuates intestinal inﬂammation in murine ex-
perimental colitis, Lab. Invest. 88 (2008) 652–663.
[36] Y. Wu, S. Antony, J.L. Meitzler, J.H. Doroshow, Molecular mechanisms underlying
chronic inﬂammation-associated cancers, Cancer Lett. 345 (2014) 164–173, http://
dx.doi.org/10.1016/j.canlet.2013.08.014.
M. Sabzevary-Ghahfarokhi et al. Pathology - Research and Practice 214 (2018) 1149–1155
1155
